Nasdaq
AGMB
AgomAb Therapeutics NV
- Health Care
- Belgium
- Listed 2026
- 1 day
- −5.7%
- 1 month
- +1.7%
- 1 year
- —
$13.50 · Mkt cap $665M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
AgomAb Therapeutics NV
$13.50 · Mkt cap $665M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
AgomAb Therapeutics NV trades under the ticker AGMB on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2026. Its market capitalisation is $665M. The last closing price was $13.50, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because AGMB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.